OpenURL Connection Search

Select item for more details and to access through your institution.

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy.
Published in:
Diabetologia, 2006, v. 49, n. 8, p. 1711, doi. 10.1007/s00125-006-0316-2
By:
- Nathan, D. M.;
- Buse, J. B.;
- Davidson, M. B.;
- Heine, R. J.;
- Holman, R. R.;
- Sherwin, R.;
- Zinman, B.
Publication type:
Article
Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN<sup>®</sup> Basal-Bolus Type 1): 2-year results of a randomized clinical trial
Published in:
Diabetic Medicine, 2013, v. 30, n. 11, p. 1293, doi. 10.1111/dme.12243
By:
- Bode, B. W.;
- Buse, J. B.;
- Fisher, M.;
- Garg, S. K.;
- Marre, M.;
- Merker, L.;
- Renard, E.;
- Russell‐Jones, D. L.;
- Hansen, C. T.;
- Rana, A.;
- Heller, S. R.
Publication type:
Article
Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN<sup>®</sup> Basal-Bolus Type 1): 2-year results of a...
Published in:
2013
By:
- Bode, B. W.;
- Buse, J. B.;
- Fisher, M.;
- Garg, S. K.;
- Marre, M.;
- Merker, L.;
- Renard, E.;
- Russell-Jones, D. L.;
- Hansen, C. T.;
- Rana, A.;
- Heller, S. R.
Publication type:
Journal Article
Patient-reported outcomes are superior in patients with Type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label study.
Published in:
Diabetic Medicine, 2011, v. 28, n. 6, p. 715, doi. 10.1111/j.1464-5491.2011.03276.x
By:
- Schmidt, W. E.;
- Christiansen, J. S.;
- Hammer, M.;
- Zychma, M. J.;
- Buse, J. B.
Publication type:
Article
Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetes.
Published in:
Diabetes, Obesity & Metabolism, 2016, v. 18, n. 1, p. 40, doi. 10.1111/dom.12574
By:
- Rodbard, H. W.;
- Buse, J. B.;
- Woo, V.;
- Vilsbøll, T.;
- Langbakke, I. H.;
- Kvist, K.;
- Gough, S. C. L.
Publication type:
Article
One-year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26-week extension to a 26-week main trial.
Published in:
Diabetes, Obesity & Metabolism, 2015, v. 17, n. 10, p. 965, doi. 10.1111/dom.12498
By:
- Gough, S. C. L.;
- Bode, B. W.;
- Woo, V. C.;
- Rodbard, H. W.;
- Linjawi, S.;
- Zacho, M.;
- Reiter, P. D.;
- Buse, J. B.
Publication type:
Article
LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results ( LEADER) trial: preliminary observations.
Published in:
Diabetes, Obesity & Metabolism, 2015, v. 17, n. 5, p. 477, doi. 10.1111/dom.12444
By:
- Daniels, G. H.;
- Hegedüs, L.;
- Marso, S. P.;
- Nauck, M. A.;
- Zinman, B.;
- Bergenstal, R. M.;
- Mann, J. F. E.;
- Derving Karsbøl, J.;
- Moses, A. C.;
- Buse, J. B.;
- Tuttle, R. M.
Publication type:
Article
Efficacy, safety and tolerability of aleglitazar in patients with type 2 diabetes: pooled findings from three randomized phase III trials.
Published in:
Diabetes, Obesity & Metabolism, 2015, v. 17, n. 6, p. 560, doi. 10.1111/dom.12455
By:
- Henry, R. R.;
- Buse, J. B.;
- Wu, H.;
- Durrwell, L.;
- Mingrino, R.;
- Jaekel, K.;
- El Azzouzi, B.;
- Andjelkovic, M.;
- Herz, M.
Publication type:
Article
Cardiovascular safety of the glucagon-like peptide-1 receptor agonist taspoglutide in people with type 2 diabetes: an individual participant data meta-analysis of randomized controlled trials.
Published in:
Diabetes, Obesity & Metabolism, 2015, v. 17, n. 5, p. 505, doi. 10.1111/dom.12448
By:
- Seshasai, S. R. K.;
- Bennett, R. L.;
- Petrie, J. R.;
- Bengus, M.;
- Ekman, S.;
- Dixon, M.;
- Herz, M.;
- Buse, J. B.;
- Ray, K. K.
Publication type:
Article
Is insulin the most effective injectable antihyperglycaemic therapy?
Published in:
Diabetes, Obesity & Metabolism, 2015, v. 17, n. 2, p. 145, doi. 10.1111/dom.12402
By:
- Buse, J. B.;
- Peters, A.;
- Russell‐Jones, D.;
- Furber, S.;
- Donsmark, M.;
- Han, J.;
- MacConell, L.;
- Maggs, D.;
- Diamant, M.
Publication type:
Article
Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort study.
Published in:
Diabetes, Obesity & Metabolism, 2014, v. 16, n. 12, p. 1247, doi. 10.1111/dom.12379
By:
- Gokhale, M.;
- Buse, J. B.;
- Gray, C. L.;
- Pate, V.;
- Marquis, M. A.;
- Stürmer, T.
Publication type:
Article
Subcutaneous injection of hyaluronidase with recombinant human insulin compared with insulin lispro in type 1 diabetes.
Published in:
Diabetes, Obesity & Metabolism, 2014, v. 16, n. 11, p. 1065, doi. 10.1111/dom.12315
By:
- Garg, S. K.;
- Buse, J. B.;
- Skyler, J. S.;
- Vaughn, D. E.;
- Muchmore, D. B.
Publication type:
Article
Options for prandial glucose management in type 2 diabetes patients using basal insulin: addition of a short-acting GLP-1 analogue versus progression to basal-bolus therapy.
Published in:
Diabetes, Obesity & Metabolism, 2014, v. 16, n. 3, p. 206, doi. 10.1111/dom.12136
By:
- Hirsch, I. B.;
- Buse, J. B.;
- Leahy, J.;
- McGill, J. B.;
- Peters, A.;
- Rodbard, H. W.;
- Rubin, R. R.;
- Skyler, J. S.;
- Verderese, C. A.;
- Riddle, M. C.
Publication type:
Article
Specific class II histocompatibility gene polymorphism in BB rats.
Published in:
1984
By:
- Buse, John B.;
- Ben-Nun, Avraham;
- Klein, Karen A.;
- Eisenbarth, George S.;
- Seidman, J. G.;
- Jackson, Richard A.;
- Buse, J B;
- Ben-Nun, A;
- Klein, K A;
- Eisenbarth, G S;
- Jackson, R A
Publication type:
journal article
Once-weekly exenatide formulation better than twice-daily regimen.
Published in:
Nurse Prescribing, 2008, v. 6, n. 10, p. 461
By:
- Drucker, D. J.;
- Buse, J. B.;
- Taylor, K.;
- Kendall, D. M.
Publication type:
Article
Troglitazone use in insulin-treated type 2 diabetic patients. The Troglitazone Insulin Study Group.
Published in:
1998
By:
- Buse, John B.;
- Gumbiner, Barry;
- Mathias, Nancy P.;
- Nelson, Debra M.;
- Faja, Barbara W.;
- Whitcomb, Randall W.;
- Buse, J B;
- Gumbiner, B;
- Mathias, N P;
- Nelson, D M;
- Faja, B W;
- Whitcomb, R W
Publication type:
journal article
Molecular biology of mammalian glucose transporters.
Published in:
1990
By:
- Bell, Graeme I.;
- Kayano, Toshiaki;
- Buse, John B.;
- Burant, Charles F.;
- Takeda, Jun;
- Lin, Denis;
- Fukumoto, Hirofumi;
- Seino, Susumu;
- Bell, G I;
- Kayano, T;
- Buse, J B;
- Burant, C F;
- Takeda, J;
- Lin, D;
- Fukumoto, H;
- Seino, S
Publication type:
journal article
Human GLUT4/muscle-fat glucose-transporter gene. Characterization and genetic variation.
Published in:
1992
By:
- Buse, John B.;
- Yasuda, Kazuki;
- Lay, Tracy P.;
- Seo, Tracy S.;
- Olson, Ann Louise;
- Pessin, Jeffrey E.;
- Karam, John H.;
- Seino, Susumu;
- Bell, Graeme I.;
- Buse, J B;
- Yasuda, K;
- Lay, T P;
- Seo, T S;
- Olson, A L;
- Pessin, J E;
- Karam, J H;
- Seino, S;
- Bell, G I
Publication type:
journal article

Found: 18